Also trades as: MPL.AX (ASX) · $vol 21M
MDBPF OTC
Medibank Private Limited
1W: +0.0%
1M: +2.9%
3M: +0.0%
YTD: +20.7%
1Y: +23.0%
3Y: +126.7%
5Y: +150.0%
$3.90
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$622M
+63.2% ▲
5Y CAGR: +4.5%
Capital Expenditures
$19M
-73.0% ▼
5Y CAGR: -11.2%
Free Cash Flow
$602M
+62.9% ▲
5Y CAGR: +5.4%
Dividends Paid
$509M
-7.4% ▼
Buybacks
$11M
-67.0% ▼
Net Change in Cash
-$46M
-8.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $394M | $511M | $492M | $501M | $638M |
| Depreciation & Amort. | $77M | $80M | $89M | $96M | $105M |
| Stock-Based Comp. | $6M | $7M | $3M | $8M | $0 |
| Change in Working Capital | $566M | -$431M | $330M | -$64M | -$145M |
| Other Non-Cash Items | $80M | $258M | -$47M | -$160M | $24M |
| Operating Cash Flow | $963M | $258M | $868M | $381M | $622M |
| — Investing Activities — | |||||
| Capital Expenditures | -$35M | -$42M | -$7M | -$11M | -$91M |
| Acquisitions (Net) | $0 | $0 | -$37M | $2M | -$159M |
| Investment Purchases | -$1.9B | -$1.7B | -$1.5B | $0 | -$33M |
| Investment Sales | $1.3B | $1.8B | $1.4B | $0 | $145M |
| Other Investing | -$5M | -$5M | $64M | $120M | $18M |
| Investing Cash Flow | -$638M | -$15M | -$111M | $110M | -$121M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$39M | -$40M | -$49M | -$47M | $899K |
| Stock Repurchased | -$3M | -$5M | -$8M | -$6M | -$11M |
| Dividends Paid | -$358M | -$374M | -$427M | -$474M | -$509M |
| Other Financing | $0 | $0 | -$4M | -$7M | -$61M |
| Financing Cash Flow | -$400M | -$419M | -$487M | -$534M | -$579M |
| Net Change in Cash | -$75M | -$176M | $270M | -$42M | -$46M |
| Cash End of Period | $597M | $421M | $691M | $649M | $570M |
| Free Cash Flow | $928M | $216M | $811M | $370M | $602M |